Deals by stage

In review M&A deals

Every published Exit Mode archive deal currently grouped under the in review stage.

Stage views help founders separate early signals from signed outcomes, making it easier to judge which deals are only surfacing, which are live, and which have reached a real endpoint.

23 May 2024In reviewHealthcare

Roche Diagnostics Limited to acquire LumiraDx Group Limited (in administration) and LumiraDx International Limited (in administration)

Roche Diagnostics Limited and LumiraDx Group Limited (in administration) and LumiraDx International Limited (in administration) entered the Exit Mode archive.

Buyer
Roche Diagnostics Limited
Target
LumiraDx Group Limited (in administration) and LumiraDx International Limited (in administration)
Deal value
Not disclosed
Deal type
strategic acquisition

Exit Mode Insider

Get the patterns behind the deals, every week

Ten curated deal briefs a week, plus founder commentary on the patterns worth paying attention to. £12/month, cancel anytime.

Join Insider, £12/mo

Keep browsing

Explore the archive from another angle

All deals